語系:
繁體中文
English
說明(常見問題)
登入
回首頁
切換:
標籤
|
MARC模式
|
ISBD
Clinical Management of Acute Lymphoblastic Leukemia = From Bench to Bedside /
紀錄類型:
書目-語言資料,印刷品 : Monograph/item
正題名/作者:
Clinical Management of Acute Lymphoblastic Leukemia/ edited by Mark R. Litzow, Elizabeth A. Raetz.
其他題名:
From Bench to Bedside /
其他作者:
Raetz, Elizabeth A.
面頁冊數:
XI, 437 p. 29 illus., 22 illus. in color.online resource. :
Contained By:
Springer Nature eBook
標題:
Internal Medicine. -
電子資源:
https://doi.org/10.1007/978-3-030-85147-7
ISBN:
9783030851477
Clinical Management of Acute Lymphoblastic Leukemia = From Bench to Bedside /
Clinical Management of Acute Lymphoblastic Leukemia
From Bench to Bedside /[electronic resource] :edited by Mark R. Litzow, Elizabeth A. Raetz. - 1st ed. 2022. - XI, 437 p. 29 illus., 22 illus. in color.online resource.
TRANSLATIONAL SCIENCE -- Molecular pathways and targets in B cell progenitor acute lymphoblastic leukemia -- Genetic Mechanisms in T-Cell Acute Lymphoblastic Leukemia -- Minimal Residual Disease in Acute Lymphoblastic Leukemia – Techniques and Application -- THERAPEUTICS -- Treatment of Pediatric B and T cell ALL -- Treatment of Adult B and T cell Acute Lymphoblastic Leukemia: An Overview of Current Treatments and Novel Advances -- Acute Lymphoblastic Leukemia in Infants: A distinctive, high risk subtype of childhood ALL -- Treatment of Elderly Patients with Acute Lymphoblastic Leukemia -- Treatment of Childhood Philadelphia-Chromosome Positive Acute Lymphoblastic Leukemia -- Treatment of adult Philadelphia chromosome positive ALL -- Treatment of Ph-like ALL -- Prophylaxis and treatment of central nervous system (CNS) ALL -- Late effects of therapy of acute lymphoblastic leukemia -- NEW AND EXISTING MODALITIES OF THERAPY -- Monoclonal Antibody Based Treatment and Other New Agents for B-Lineage ALL -- New Agents for the Treatment of T-Cell ALL -- The development and management of treatment with chimeric-antigen receptor T cell (CAR-T) -- Hematopoietic Stem Cell Transplantation in Adults with Acute Lymphoblastic Leukemia (ALL) -- Hematopoietic Stem Cell Transplantation in Pediatric Acute Lymphoblastic Leukemia.
This book provides a state-of-the-art overview of acute lymphoblastic leukemia (ALL). The first section of the book presents the translational science behind ALL, reviewing molecular pathways and targets in B- and T-cell ALL, as well as techniques and application of minimal residual disease testing. The second section spotlights ALL management strategies for patients across the spectrum, from infants to the elderly. The final section outlines current and new advances in ALL treatment, including new monoclonal antibodies and allogenic and autologous HSCT. Written by experts in the field, Clinical Management of Acute Lymphoblastic Leukemia: From Bench to Bedside is a valuable resource that will guide patient management, stimulate investigative efforts, and increase understanding of the biologic underpinnings of the disease.
ISBN: 9783030851477
Standard No.: 10.1007/978-3-030-85147-7doiSubjects--Topical Terms:
668583
Internal Medicine.
LC Class. No.: RC1-1245
Dewey Class. No.: 616
Clinical Management of Acute Lymphoblastic Leukemia = From Bench to Bedside /
LDR
:03635nam a22004455i 4500
001
1091943
003
DE-He213
005
20220113145225.0
007
cr nn 008mamaa
008
221228s2022 sz | s |||| 0|eng d
020
$a
9783030851477
$9
978-3-030-85147-7
024
7
$a
10.1007/978-3-030-85147-7
$2
doi
035
$a
978-3-030-85147-7
050
4
$a
RC1-1245
050
4
$a
RC1-1245
072
7
$a
MJ
$2
bicssc
072
7
$a
MJ
$2
bicssc
072
7
$a
MED038000
$2
bisacsh
072
7
$a
MJ
$2
thema
072
7
$a
MJ
$2
thema
082
0 4
$a
616
$2
23
082
0 4
$a
616
$2
23
245
1 0
$a
Clinical Management of Acute Lymphoblastic Leukemia
$h
[electronic resource] :
$b
From Bench to Bedside /
$c
edited by Mark R. Litzow, Elizabeth A. Raetz.
250
$a
1st ed. 2022.
264
1
$a
Cham :
$b
Springer International Publishing :
$b
Imprint: Springer,
$c
2022.
300
$a
XI, 437 p. 29 illus., 22 illus. in color.
$b
online resource.
336
$a
text
$b
txt
$2
rdacontent
337
$a
computer
$b
c
$2
rdamedia
338
$a
online resource
$b
cr
$2
rdacarrier
347
$a
text file
$b
PDF
$2
rda
505
0
$a
TRANSLATIONAL SCIENCE -- Molecular pathways and targets in B cell progenitor acute lymphoblastic leukemia -- Genetic Mechanisms in T-Cell Acute Lymphoblastic Leukemia -- Minimal Residual Disease in Acute Lymphoblastic Leukemia – Techniques and Application -- THERAPEUTICS -- Treatment of Pediatric B and T cell ALL -- Treatment of Adult B and T cell Acute Lymphoblastic Leukemia: An Overview of Current Treatments and Novel Advances -- Acute Lymphoblastic Leukemia in Infants: A distinctive, high risk subtype of childhood ALL -- Treatment of Elderly Patients with Acute Lymphoblastic Leukemia -- Treatment of Childhood Philadelphia-Chromosome Positive Acute Lymphoblastic Leukemia -- Treatment of adult Philadelphia chromosome positive ALL -- Treatment of Ph-like ALL -- Prophylaxis and treatment of central nervous system (CNS) ALL -- Late effects of therapy of acute lymphoblastic leukemia -- NEW AND EXISTING MODALITIES OF THERAPY -- Monoclonal Antibody Based Treatment and Other New Agents for B-Lineage ALL -- New Agents for the Treatment of T-Cell ALL -- The development and management of treatment with chimeric-antigen receptor T cell (CAR-T) -- Hematopoietic Stem Cell Transplantation in Adults with Acute Lymphoblastic Leukemia (ALL) -- Hematopoietic Stem Cell Transplantation in Pediatric Acute Lymphoblastic Leukemia.
520
$a
This book provides a state-of-the-art overview of acute lymphoblastic leukemia (ALL). The first section of the book presents the translational science behind ALL, reviewing molecular pathways and targets in B- and T-cell ALL, as well as techniques and application of minimal residual disease testing. The second section spotlights ALL management strategies for patients across the spectrum, from infants to the elderly. The final section outlines current and new advances in ALL treatment, including new monoclonal antibodies and allogenic and autologous HSCT. Written by experts in the field, Clinical Management of Acute Lymphoblastic Leukemia: From Bench to Bedside is a valuable resource that will guide patient management, stimulate investigative efforts, and increase understanding of the biologic underpinnings of the disease.
650
1 4
$a
Internal Medicine.
$3
668583
650
0
$a
Internal medicine.
$3
644638
700
1
$a
Raetz, Elizabeth A.
$e
editor.
$4
edt
$4
http://id.loc.gov/vocabulary/relators/edt
$3
1399634
700
1
$a
Litzow, Mark R.
$e
editor.
$4
edt
$4
http://id.loc.gov/vocabulary/relators/edt
$3
1399633
710
2
$a
SpringerLink (Online service)
$3
593884
773
0
$t
Springer Nature eBook
776
0 8
$i
Printed edition:
$z
9783030851460
776
0 8
$i
Printed edition:
$z
9783030851484
776
0 8
$i
Printed edition:
$z
9783030851491
856
4 0
$u
https://doi.org/10.1007/978-3-030-85147-7
912
$a
ZDB-2-SME
912
$a
ZDB-2-SXM
950
$a
Medicine (SpringerNature-11650)
950
$a
Medicine (R0) (SpringerNature-43714)
筆 0 讀者評論
多媒體
評論
新增評論
分享你的心得
Export
取書館別
處理中
...
變更密碼[密碼必須為2種組合(英文和數字)及長度為10碼以上]
登入